| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |